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ies]. ConClusions: PCPDs contribute to improving QOL for patients at the EoL and 
reduce the time they spend in the ICU. This systematic review is part of a mega-
analysis (a multi-intervention appraisal) about EoL care, and its recommendations 
will inform policies regarding the delivering quality EoL care for Ontarians.
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objeCtives: Many persons with schizophrenia qualify for Medicaid coverage, thus 
prompt re-acquisition of Medicaid eligibility following release from incarceration 
should lower the risk of re-incarceration. The objective of this study was to assess 
the effect of Medicaid eligibility on risk of re-incarceration among schizophrenia 
diagnosed subjects. Methods: Study subjects were selected between 1/1/2006 and 
9/30/2011 from a Medicaid database merged with department of corrections data 
for a single state. Subjects were adults (18-62 years) with diagnosed schizophrenia 
(ICD 9-CM= 295.xx). Covariates included age, race, gender, marital status, and rea-
son for incarceration. Time to Medicaid eligibility post-release, cumulative days of 
eligibility, and eligibility on re-incarceration date were evaluated in two independ-
ent Cox regression models (1 and 3-year followup) evaluating the hazard for re-
incarceration. Results: A total of 932 subjects were included: 26.5% white, 73.7% 
male, 73.5% single/divorced, 12.7% incarcerated for a substance abuse violation, 
average age 37.6 years. Over the one-year follow-up period, 110 subjects (11.8%) were 
re-incarcerated while over three year follow-up, 209 (22.4%) were re-incarcerated. 
Age (in years) was the only significant predictor of re-incarceration for the one 
year model (HR = 0.976, 95% CI 0.957, 0.994). Eligibility was a significant predictor 
in the three-year follow-up model. A longer ‘time to first eligibility’ (HR = 1.046, 95% 
CI= 1.017, 1.075) was associated with a greater hazard for re-incarceration. Being 
Medicaid eligible at the time of re-incarceration (HR= 0.659, 95% CI = 0.498, 0.870), the 
cumulative number of months of eligibility (HR= 0.978, 95% CI= 0.958, 0.997) and age 
were associated with a lower hazard for re-incarceration (HR= 0.986, 95% CI= 0.973, 
0.999). ConClusions: Among schizophrenia diagnosed subjects, Medicaid eligibil-
ity at release and older age were associated with a lower risk of re-incarceration. 
Access to Medicaid and associated health services post-release may be a factor in 
helping to reduce re-incarceration risk.
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objeCtives: Three draft measures have been proposed by the Pharmacy Quality 
Alliance’s Medication Safe Use Workgroup to examine the quality of opioid use 
related to the dose of the medications over time, access to the medications and 
the combination of both of these criteria. The purpose of this study was to conduct 
a sensitivity analysis so as to identify the appropriate thresholds that should be 
utilized in the numerator of these preliminary measures. Methods: Medicaid fee-
for-service beneficiaries aged ≥ 18 years, with continuous 12 month enrollment, 
and two or more prescription claims for opioids that total ≥ 15 days supply on at 
least two separate days during 2012 were identified in the Mississippi Medicaid 
administrative claims data. Representative opioids comprised of those included 
in the ‘CDC Injury Center Morphine Milligram Equivalent (MME) Table.’ Morphine 
Equivalent Dose (MED) was calculated using the following formula: (Submitted 
Quantity*Strength*MME Conversion Factor)/Days Supply. Unique prescribers and 
pharmacies were identified by their national provider identifier number. Results: 
The sample (10,297 beneficiaries) was predominantly female (73.0%), Caucasian 
(52.2%), and had an average age of 44.33 years. 2.6% (6.3%) and 1.9% (5.3%) of the 
beneficiaries received prescriptions for opioids > 100mg MED and > 120mg MED 
respectively, for ≥ 90 consecutive (non-consecutive) days. 21.9% (5.9%) of the benefi-
ciaries received prescriptions for opioids from ≥ 4 prescribers OR (AND) ≥ 4 pharma-
cies. 0.34% (0.11%) and 1.25% (0.42%) beneficiaries received prescriptions for opioids 
> 120mg MED for ≥ 90 consecutive and nonconsecutive days respectively, and from 
≥ 4 prescribers OR (AND) ≥ 4 pharmacies. ConClusions: The sensitivity analysis 
revealed data for critical decision points for the PQA Workgroup. Health plans that 
are considering the adoption of similar measures, in order to plan their respective 
interventions, will benefit from seeing the breakdown.
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objeCtives: We examined the association between depression and Ambulatory 
Care Sensitive Hospitalizations (ACSH) among Medicare beneficiaries. Methods: 
We adopted a retrospective cross-sectional design using merged survey and fee-for-
service Medicare claims data from 2002-2009 Medicare Current Beneficiary Survey. 
Our study sample consisted of community-dwelling fee-for-service Medicare enroll-
ees with any of the following chronic conditions: arthritis, cancer, diabetes, heart 
disease, hypertension, respiratory diseases, and osteoporosis. ACSH and depression 
were identified using ICD-9-CM Codes. The dependent variables were: any “chronic 
ACSH” (diabetes short-term complications, diabetes long-term complications, 
chronic obstructive pulmonary disease (COPD), hypertension, congestive heart fail-
ure (CHF), angina without a procedure, uncontrolled diabetes, adult asthma and/or 
lower extremity amputations) and “acute ACSH” (dehydration, bacterial pneumonia 
and/or urinary infections), and “any ACSH”. We separately examined ACSH for CHF, 
objeCtives: Determine the factors influencing mammography prescription dur-
ing physician office visits in the U.S and to also determine whether primary care 
physicians or gynecological practitioners have a higher likelihood of prescribing 
mammograms. The study will also examine the possible change in the likelihood 
of mammography prescription over time for different age groups during 2008-2010 
as a result of the 2009 USPSTF screening recommendations. Methods: This cross-
sectional study uses data from National Ambulatory Medical Care Survey. The study 
sample consists of female patients > 40 years, who had a physician office visit in 
the US during 2008-2010. Women with current diagnosis of breast cancer were 
excluded from the study. Logistic regressions were used for the analysis. Results: 
Women visiting a physician for preventive care were approximately eight times 
more likely to be prescribed a mammogram (OR:7.916, 95%CI:4.697-13.340). Women 
residing in non-metropolitan statistical areas were less likely to be prescribed a 
mammogram (OR:0.461, 95%CI:0.238-0.893). Mammography prescription by physi-
cians did not vary by race-ethnicity, insurance coverage, region of residence and 
time spent with the physician. As compared to primary care physicians, obstetrics 
and gynecologist were two times more likely to prescribe a mammogram (OR:2.713 
95%CI:1.395-5.277). In the year 2008 and 2010, there were no statistically significant 
differences in mammography prescriptions across age groups. However in 2009, 
women aged 50-54 (OR:2.053 95%CI:1.061-3.975), 55-59 (OR:2.085 95%CI:1.063-4.089), 
60-64 (OR:2.037 95%CI:1.100-3.775) and 70-74 (OR:2.511 95%CI:1.047-6.026) were two 
times more likely to get a mammography prescription as compared to 40-49 year 
old women. ConClusions: Physician specialty, nature of visit and residence in 
metropolitan statistical areas are important determinants of receiving a mammog-
raphy prescription. In the year 2009 there was a fall in mammography prescription 
for 40-49 year old women as compared to older age groups, however this drop did 
not persist in 2010.
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objeCtives: The aim of this study was to evaluate the impact of missed clinic 
appointments on the time in therapeutic international normalized ratio range (TTR) 
in an inner-city underserved minority population. Methods: A cross-sectional 
survey and cohort study were conducted in patients treated with warfarin and 
managed at the University of Illinois at Chicago Antithrombosis Clinic. Patient 
social, demographic, and clinical characteristics were compared using paramet-
ric and non-parametric tests as appropriate and weighted linear regression using 
propensity scores was performed to identify the association between patients with 
≥ 15% missed clinic appointments and TTR. Results: A total of 291 consecutive 
patients responded to the survey and were included in the study. Patients with ≥ 
15% missed clinic appointments had lower mean age (51.36 ± 17.62 vs. 57.18 ± 16.97, 
p = 0.0051), lower TTR (44.97 ± 19.63 vs. 53.25 ± 20.36 p = 0.0007), a higher number of 
total clinic appointments for monitoring (21.25 ± 8.37 vs. 16.28 ± 7.73, p = < 0.0001), 
higher non-adherence with warfarin therapy (16.10 ± 14.02 vs. 10.22 ± 12.85, p = 
< 0.0001) and longer duration of therapy (4.38 ± 5.91 years vs. 2.71 ± 3.26 years, p = 
0.0009) compared to patients with < 15% missed clinic appointments. Based on the 
results of the unadjusted bivariate regression model, patients with ≥ 15% missed 
clinic appointments had significantly lower TTR (β = -8.43, 95% CI: -13.10, -3.76, p 
= 0.0004). After adjusting for confounders using inverse probability weights, the 
association between missed clinic appointments and TTR remained significant (β = 
-6.30, 95% CI: -11.18, -1.42, p = 0.0115). ConClusions: Missed clinic appointments 
for anticoagulation management negatively affected the quality of anticoagula-
tion control. Future studies should evaluate factors associated with missed clinic 
appointments and the feasibility of more accessible high-quality models of care in 
underserved minorities.
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objeCtives: This evidence-based analysis (EBA) is a systematic review of the effec-
tiveness of patient care planning discussions (PCPDs) between patients/ families 
and providers in improving patient-centred outcomes for people nearing the end 
of life (EoL). Methods: A literature search was performed using MEDLINE, Embase, 
CINAHL, and EBM Reviews for studies published from January 1, 2004 to October 9, 
2013. Included studies must be in English, include adults at the EoL, utilize selected 
study designs [i.e. randomized controlled trials (RCTs), observational studies, sys-
tematic reviews, meta-analyses], and focus on discussion-based interventions for 
planning EoL care. Titles and abstracts were reviewed by a single reviewer and full-
text articles were obtained when appropriate. Reference lists were examined for 
additional relevant studies. The quality of the evidence was evaluated using GRADE. 
When appropriate, meta-analyses were performed. Results: The search yielded 
5,316 citations, and 13 RCTs and 17 observational studies were selected for inclusion 
in the quantitative evidence synthesis, which is still underway. Preliminary results 
showed that, compared to no PCPDs, PCPDs involving providers from at least one 
discipline led to increases in quality of life (QOL). Interventions that included tools 
to facilitate PCPDs (e.g. question list) did not perform better than their controls (2 
studies showing mean differences of 0.01, p> 0.05 and 0.10, p> 0.05). Having PCPDs 
earlier in the illness course was associated with higher QOL (adjβ = 0.003, p= 0.006; 
1 study). PCPDs with a multidisciplinary team of providers led to fewer days in 
the intensive care unit (ICU) [pooled estimate: -6.68 (95% CI: -10.71, -2.65); 2 stud-
